FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

FHIR IG Statistics (157 ms)

ValueSets, Realm EU, Authority Hl7, Version R4

365 resources

Source:
Text: Use quotation marks (") for an exact phrase. You can use AND, OR, and NOT. Wildcard = *

Rows 0 - 200 Next
PackageIdentityName/TitleStatusDateSource(s)
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIActiveIngredient eHDSI Active Ingredientdraft2024-11atc
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIAdverseEventType eHDSI Adverse Event Typedraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIAllergenNoDrug eHDSI Allergen No Drugdraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIAllergyCertainty eHDSI Allergy Certaintydraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIAllergyStatus eHDSI Allergy Statusdraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIAnimalSpecies eHDSI Animal Speciesdraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup eHDSI Blood Groupdraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIBloodPressure eHDSI Blood Pressuredraft2024-11loinc
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIBodySite eHDSI Body Sitedraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIBodySiteLaterality eHDSI Body Site Lateralitydraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIBodyStructureLocation eHDSI Body Structure Location Qualifierdraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSICertainty eHDSI Certaintydraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSICodeProb eHDSI Code Probdraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSICountry eHDSI Countrydraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSICriticality eHDSI Criticalitydraft2024-11fhir
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSICurrentPregnancyStatus eHDSI Current Pregnancy Statusdraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIDisplayLabel eHDSI Display Labeldraft2024-11oid
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIDocumentCode eHDSI Document Codedraft2024-11loinc
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIDoseForm eHDSI Dose Formdraft2024-11
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIExceptionalValue eHDSI Exceptional Valuedraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIHealthcareProfessionalRole eHDSI Healthcare Professional Roledraft2024-11oid
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSILabCode eHDSI Laboratory Codesdraft2024-11loinc
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSILabSpecimenType eHDSI Laboratory Specimen Typedraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSILabStudyType eHDSI Laboratory Study Typesdraft2024-11loinc
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSILabTechnique eHDSI Laboratory Techniquedraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSILaboratoryReportTypes eHDSI Laboratory Report Typesdraft2024-11loinc
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSILanguage eHDSI Languagedraft2024-11ietf
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIMedicalDevice eHDSI Medical Devicedraft2024-11sct oid
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIMedicalImagesType eHDSI Medical Images Typedraft2024-11loinc
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIMedicalImagingReportType eHDSI Medical Imaging Report Typedraft2024-11loinc
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIMicroorganism eHDSI Microorganismdraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIMorphologicAbnormality eHDSI Morphologic Abnormalitydraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIObservationCategory eHDSI Observation categorydraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIObservationInterpretation eHDSI Observation Interpretationdraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIOutcomeOfPregnancy eHDSI Outcome of Pregnancydraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIPackage eHDSI Packagedraft2024-11
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIPerformerFunction eHDSI Performer Functiondraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIPersonalRelationship eHDSI PersonalRelationshipdraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIPregnancyInformation eHDSI PregnancyInformationdraft2024-11loinc
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIPresenceAbsence eHDSI Presence Absencedraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIProcedure eHDSI Proceduredraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIQuantityUnit eHDSI Quantity Unitdraft2024-11
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIRareDisease eHDSI Rare Diseasedraft2024-11
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy eHDSI Reaction Allergydraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIReferenceRangeAppliesTo eHDSI Reference Range Applies Todraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIReferenceRangeMeaning eHDSI Reference Range Meaningdraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIResolutionOutcome eHDSI Resolution Outcomedraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIRoleClass eHDSI Role Classdraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIRouteofAdministration eHDSI Route of Administrationdraft2024-11
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSISection eHDSI Sectiondraft2024-11loinc
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSISeverity eHDSI Severitydraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSISocialHistory eHDSI Social Historydraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIStatusCode eHDSI Status Codedraft2024-11sct
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSISubstance eHDSI Substancedraft2024-11
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSISubstitutionCode eHDSI Substitution Codedraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSITelecomAddress eHDSI Telecom Addressdraft2024-11tho
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSITimingEvent eHDSI Timing Eventdraft2024-11tho oid
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIUnit eHDSI Unitdraft2024-11ucum
hl7.eu.terminology.ehdsihttp://terminology.ehdsi.eu/ValueSet/eHDSIVaccine eHDSI Vaccinedraft2024-11atc sct
hl7.eu.fhir.xpandh.hdrTNM-M-category-vs TNM M Categoryactive2024-11internal
hl7.eu.fhir.xpandh.hdrTNM-M-clinical-category-vs Clinical Mactive2024-11sct
hl7.eu.fhir.xpandh.hdrTNM-M-pathologycal-category-vs Pathological Mactive2024-11sct
hl7.eu.fhir.xpandh.hdrTNM-N-category-vs TNM N Categoryactive2024-11internal
hl7.eu.fhir.xpandh.hdrTNM-N-clinical-category-vs Clinical Nactive2024-11sct
hl7.eu.fhir.xpandh.hdrTNM-N-pathological-category-vs Pathological Nactive2024-11sct
hl7.eu.fhir.xpandh.hdrTNM-T-category-vs Primary tumor Tactive2024-11internal
hl7.eu.fhir.xpandh.hdrTNM-T-clinical-category-vs Clinical Tactive2024-11sct
hl7.eu.fhir.xpandh.hdrTNM-T-pathological-category-vs Pathological Tactive2024-11sct
hl7.eu.fhir.xpandh.hdradmission-voluntary-status-vs Encounter Voluntary Status Value Setdraft2024-11sct
hl7.eu.fhir.xpandh.hdrallergy-intolerance-substances-xpandh-vs AllergyIntoleranceSubstancesXpandhVSdraft2024-11sct
hl7.eu.fhir.xpandh.hdrallergy-intolerance-xpandh-vs Allergy Intolerance - Xpandhdraft2024-11internal fhir
hl7.eu.fhir.xpandh.hdranthropometric-observation-vs Anthropometric Observation Value Setdraft2024-11internal sct
hl7.eu.fhir.xpandh.hdrassessment-observation-category-vs Xpandh Assessment Observation Categoryactive2024-11internal
hl7.eu.fhir.xpandh.hdrbmi-observation-unit-vs BMI Observation Unit Value Setdraft2024-11ucum
hl7.eu.fhir.xpandh.hdrbmi-observation-vs BMI Observation Value Setdraft2024-11sct
hl7.eu.fhir.xpandh.hdrbody-height-observation-vs Body Height Observation Value Setdraft2024-11sct
hl7.eu.fhir.xpandh.hdrbody-weight-observation-vs Body Weight Observation Value Setdraft2024-11sct
hl7.eu.fhir.xpandh.hdrbody-weight-units-vs Body Weight Observation Value Setdraft2024-11ucum
hl7.eu.fhir.xpandh.hdrcancer-stage-grading-vs Cancer Stage Grading: Snomed CTdraft2024-11sct
hl7.eu.fhir.xpandh.hdrcancer-stageGroup-vs Cancer Stage Group: SNOMED CTdraft2024-11sct
hl7.eu.fhir.xpandh.hdrcircumference-observation-vs Circumference Observation Value Setdraft2024-11sct
hl7.eu.fhir.xpandh.hdrencounter-status-vs-eu-hdr In-patient Encounter Type Value Setdraft2024-11fhir
hl7.eu.fhir.xpandh.hdrfunctional-assessment-scales-vs Xpandh Functional Assessment Scalesactive2024-11sct
hl7.eu.fhir.xpandh.hdrhdr-admission-urgency-xpandh-vs Admission Urgency Value Setdraft2024-11tho
hl7.eu.fhir.xpandh.hdrhdr-condition-mandatory-xpandh-vs Mandatory Condition Value Setdraft2024-11internal fhir sct
hl7.eu.fhir.xpandh.hdrhdr-condition-xpandh-vs Condition Value Setdraft2024-11sct icd
hl7.eu.fhir.xpandh.hdrhdr-encounter-type-xpandh-vs In-patient Encounter Type Value Setdraft2024-11sct
hl7.eu.fhir.xpandh.hdrhdr-encounterClass-xpandh-vs Encounter Class Value Setdraft2024-11tho
hl7.eu.fhir.xpandh.hdrhdr-poa-indicator-xpandh-vs Condition Present on Admission (POA) Value Setdraft2024-11internal
hl7.eu.fhir.xpandh.hdrhdr-treated-xpandh-vs Treatment Class Value Setdraft2024-11sct
hl7.eu.fhir.xpandh.hdrmcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-11loinc
hl7.eu.fhir.xpandh.hdrmcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-11loinc
hl7.eu.fhir.xpandh.hdrmcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-11loinc
hl7.eu.fhir.xpandh.hdrmedical-devices-snomed-absent-unknown-xpandh-vs Medical Devices - SNOMED CT + Absent/Unknown - IPSdraft2024-11internal fhir
hl7.eu.fhir.xpandh.hdrmedical-devices-xpandh-vs Medical Devices (SNOMED CT) - Xpandhdraft2024-11sct
hl7.eu.fhir.xpandh.hdrmedication-snomed-absent-unknown-uv-ips Medications - SNOMED CT + Absent/Unknown (IPS)active2024-11fhir sct
hl7.eu.fhir.xpandh.hdrprocedure-snomed-xpandh-vs Procedure codes: Snomed CTdraft2024-11sct
hl7.eu.fhir.xpandh.hdrprocedures-snomed-absent-unknown-xpandh-vs Procedures - SNOMED CT + Absent/Unknown - IPSdraft2024-11fhir sct
hl7.eu.fhir.xpandh.hdrskinfold-thickness-units-vs Skinfold Thickness Units Value Setdraft2024-11ucum
hl7.eu.fhir.xpandh.hdrskinfold-thickness-vs Skinfold Thickness Value Setdraft2024-11sct
hl7.eu.fhir.xpandh.hdrvital-signs-observation-vs Vital Signs Observation Value Setdraft2024-11internal sct
hl7.eu.fhir.xpandh.hdrwhodas-code-vs Xpandh WHODAS Codes Valuesetactive2024-11
hl7.eu.fhir.xpandh.hdrwhodas-domain-vs Xpandh WHODAS Domain Valuesetactive2024-11
hl7.eu.fhir.xpandh.hdrwhodas-result-vs Xpandh WHODAS Result Valuesetactive2024-11
hl7.eu.fhir.fluteVS-BiopsyType Type of Biopsydraft2024-09sct
hl7.eu.fhir.fluteVS-DREOutcomeCode DRE Observation Interpretation Codesdraft2024-09sct
hl7.eu.fhir.fluteVS-GleasonGrade Gleason Gradedraft2024-09loinc
hl7.eu.fhir.fluteVS-PCa Malignant tumor of prostate Value Setdraft2024-09sct
hl7.eu.fhir.fluteVS-PiRads Prostate Imaging – Reporting and Data Systemdraft2024-09
hl7.eu.fhir.idea4rcGender-i4rc Gender: Athenaactive2024-11
hl7.eu.fhir.idea4rcalcoholUsageStatus-athena-eu-i4rc Alcohol Usage Status: Athenaactive2024-11
hl7.eu.fhir.idea4rcalcoholUsageStatus-snomed-eu-i4rc Alcohol Usage Status: SNOMED CTactive2024-11sct
hl7.eu.fhir.idea4rcbeam-quality-i4rc Beam Qualityactive2024-11
hl7.eu.fhir.idea4rccancer-chondroOsseousTumours-athena-vs Cancer Chondro Osseous Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-diagnosis-athena-vs Cancer diagnosis: Athenadraft2024-11internal
hl7.eu.fhir.idea4rccancer-estAndRelatedTumours-athena-vs Cancer Endometrial stromal and related Tumors: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-event-type-vs Cancer Event Type: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-histologyAdenocarcinoma-athena-vs Cancer Histology Adenocarcinoma: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-histologyNeuroendocrine-athena-vs Cancer Histology Neuroendocrine: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-histologyOdontogenicCarcinoma-athena-vs Cancer Histology Odontogenic Carcinoma: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-histologySNUC-athena-vs Cancer Histology SNUC: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-histologySquamous-athena-vs Cancer Histology Squamous: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-histologySubgroupAdipocyticTumours-athena-vs Cancer Histology Subgroup Adipocytic Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-histologySubgroupFmtTumours-athena-vs Cancer Histology Subgroup Fmt Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-miscellaniousMesenchimalTumors-athena-vs Cancer Miscellanious mesenchimal tumors: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-mixedEpithelialAndMesenchymalTumours-athena-vs Cancer Mixed epithelial and mesenchymal tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-pericyticPerivascularTumours-athena-vs Cancer Pericytic Perivascular Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-peripheralNerveSheathTumours-athena-vs Cancer Peripheral Nerve Sheath Tumors: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-skeletalMuscleTumours-athena-vs Cancer Skeletal Muscle Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-smoothMuscleTumours-athena-vs Cancer Smooth Muscle Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-socalledFibrohistiocyticTumours-athena-vs Cancer Histology Subgroup So called Fibrohistiocytic Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-stageGrading-athena-vs Cancer Stage Grading: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-stageGroup-athena-vs Cancer Stage Group: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-stageGroupValue-athena-vs Cancer Stage Group Value: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-tumoursOfUncertainDifferentiation-athena-vs Cancer Tumors Of Uncertain Differentiation: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-undifSmallRCelSarcBonAndSofTis-athena-vs Cancer undif. small round cell sarcomas of bone and soft tissue: Athenadraft2024-11
hl7.eu.fhir.idea4rccancer-vascularTumours-athena-vs Cancer Vascular Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcchemo-units-eu-i4rc Chemotherapy cumulative dose unitsdraft2024-11ucum
hl7.eu.fhir.idea4rccomorbidities-athena-eu-i4rc Comorbidities: Athenaactive2024-11
hl7.eu.fhir.idea4rccomorbidities-sct-eu-i4rc Comorbidities: SNOMEDactive2024-11sct
hl7.eu.fhir.idea4rccountry-eu-i4rc Country: athenaactive2024-11
hl7.eu.fhir.idea4rcdisease-extent-category-vs Sarcoma Staging: localized diseasedraft2024-11
hl7.eu.fhir.idea4rcdrugsAtc-eu-i4rc Antineoplastic and immunostimulating agentsdraft2024-11atc
hl7.eu.fhir.idea4rcecog-i4rc ECOG Performance Statusactive2024-11
hl7.eu.fhir.idea4rcevent-type-eu-i4rc Event Typeactive2024-11
hl7.eu.fhir.idea4rcextranodal-extension-i4rc Extranodal Extensiondraft2024-11
hl7.eu.fhir.idea4rcgeneticTestPerformed-eu-i4rc Genetic Tests performed (Yes/no/Unk)active2024-11internal
hl7.eu.fhir.idea4rcgenito-urinary-subsite-athena-i4rc Genito urinary subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rchypopharynx-subsite-athena-i4rc Hypopharynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rchypopharynx-subsite-sct-i4rc Hypopharynx subsite: Snomed CTactive2024-11sct
hl7.eu.fhir.idea4rcintra-abdominal-subsite-athena-i4rc Intra abdominal subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcintra-thoracic-subsite-athena-i4rc Intra thoracic subsite : Athenaactive2024-11
hl7.eu.fhir.idea4rclarynx-subsite-athena-i4rc Larynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rclarynx-subsite-sct-i4rc Larynx subsite: Snomed CTactive2024-11sct
hl7.eu.fhir.idea4rclip-subsite-athena-i4rc Lip subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rclip-subsite-sct-i4rc Lip subsite: Snomed CTactive2024-11sct
hl7.eu.fhir.idea4rclocoregional-category-vs Sarcoma Staging: loco-regional categorydraft2024-11
hl7.eu.fhir.idea4rcmargins-after-surgery-eu-i4rc Margins After Surgeryactive2024-11
hl7.eu.fhir.idea4rcmcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-11loinc
hl7.eu.fhir.idea4rcmcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-11loinc
hl7.eu.fhir.idea4rcmcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-11loinc
hl7.eu.fhir.idea4rcmcode-tnm-distant-metastases-category-vs TNM Distant Metastases Category Value Setdraft2024-11
hl7.eu.fhir.idea4rcmcode-tnm-primary-tumor-category-vs TNM Primary Tumor Category Value Setdraft2024-11
hl7.eu.fhir.idea4rcmcode-tnm-regional-nodes-category-vs TNM Regional Nodes Category Value Setdraft2024-11
hl7.eu.fhir.idea4rcmetastasis-disorder-athena-vs Metastatis: Athenadraft2024-11
hl7.eu.fhir.idea4rcnasal-paranasal-subsite-athena-i4rc Nasal cavity and paranasal sinuses subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcnasal-paranasal-subsite-sct-i4rc Nasal cavity and paranasal sinuses subsite: Snomed CTactive2024-11sct
hl7.eu.fhir.idea4rcnasal-subsite-athena-i4rc Subsites: Athenaactive2024-11internal
hl7.eu.fhir.idea4rcnasal-subsite-sct-i4rc Subsites: SNOMED CTactive2024-11sct
hl7.eu.fhir.idea4rcnasopharynx-subsite-athena-i4rc Nasopharynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcnasopharynx-subsite-sct-i4rc Nasopharynx subsite: Snomed CTactive2024-11sct
hl7.eu.fhir.idea4rcobsYesNo-code-eu-i4rc Types of Yes/No observationsactive2024-11internal
hl7.eu.fhir.idea4rcoccurrence-other-cancer-i4rc Occurrence of other canceractive2024-11
hl7.eu.fhir.idea4rcoralCavity-subsite-athena-i4rc Oral cavity subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcoralCavity-subsite-sct-i4rc Oral cavity subsite: Snomed CTactive2024-11sct
hl7.eu.fhir.idea4rcoropharynx-subsite-athena-i4rc Oropharynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcoropharynx-subsite-sct-i4rc Oropharynx subsite: Snomed CTactive2024-11sct
hl7.eu.fhir.idea4rcpathologicalM-i4rc Pathological Mactive2024-11
hl7.eu.fhir.idea4rcpathologicalN-i4rc Pathological Nactive2024-11
hl7.eu.fhir.idea4rcpathologicalT-i4rc Pathological Tactive2024-11
hl7.eu.fhir.idea4rcpos-neg-nt-athena-eu-i4rc Positive-Negative-No Test: Athenaactive2024-11
hl7.eu.fhir.idea4rcrace-i4rc Raceactive2024-11
hl7.eu.fhir.idea4rcreason-for-end-of-treatment-eu-i4rc Reason For End Of Treatmentactive2024-11
hl7.eu.fhir.idea4rcsetting-radiotherapy-i4rc Setting Radiotherapyactive2024-11
hl7.eu.fhir.idea4rcsimpleResult-eu-i4rc Simple measuresactive2024-11
hl7.eu.fhir.idea4rcsite-of-metastasis-i4rc Site of metastasisactive2024-11
hl7.eu.fhir.idea4rcsite-qualifier-i4rc Body site qualifieractive2024-11
hl7.eu.fhir.idea4rcsiteRare-i4rc Site rare (IDEA4RC)active2024-11sct
hl7.eu.fhir.idea4rcsmokingStatus-athena-eu-i4rc Current Smoking Status: Athenaactive2024-11
hl7.eu.fhir.idea4rcsmokingStatus-loinc-eu-i4rc Smoking Status: LOINCactive2024-11loinc
hl7.eu.fhir.idea4rcstatus-last-followup-i4rc Status at the Last Follow Upactive2024-11internal
hl7.eu.fhir.idea4rcsurgery-complication-eu-i4rc Surgery Complicationactive2024-11
hl7.eu.fhir.idea4rcsurgery-intention-eu-i4rc Surgery Intentionactive2024-11
hl7.eu.fhir.idea4rcsurgery-outcome-eu-i4rc Surgery Outcomeactive2024-11
hl7.eu.fhir.idea4rcsurgical-complications-eu-i4rc Surgical Complicationsactive2024-11
hl7.eu.fhir.idea4rctobacco-product-eu-i4rc Tobacco Productactive2024-11
hl7.eu.fhir.idea4rctreatment-completed-as-planned-i4rc Treatment completed as plannedactive2024-11
hl7.eu.fhir.idea4rctreatment-response-eu-i4rc Treatment Responseactive2024-11
hl7.eu.fhir.idea4rctreatment-setting-eu-i4rc Treatment Settingactive2024-11
hl7.eu.fhir.idea4rctreatment-technique-i4rc Treatment Techniqueactive2024-11

XIG built as of 01 Dec 2024. Found 40907 resources in 704 packages.